Retraction Note: Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium
© Suurmond et al. 2015
Received: 1 November 2015
Accepted: 2 November 2015
Published: 9 December 2015
The original article was published in Arthritis Research & Therapy 2011 13:R150
The authors retract this article  following an investigation by Leiden University Medical Centre into the research activities of the last author. The investigation identified a discrepancy between the data reported in the article and the original collected data. The investigation committee concluded that this undermined the scientific basis of the publication and advised that the publication should be retracted.
The online version of this article contains the full text of the retracted article as electronic supplementary material (Additional file 1).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Suurmond J, Dorjée AL, Boon MR, Knol EF, Huizinga TWJ, Toes REM, et al. Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium. Arthritis Res Ther. 2011;13:R150.PubMed CentralView ArticlePubMedGoogle Scholar